Form 4: BIO-key International CEO and Chairman Michael DePasquale Buys 4,000 Shares

BIO-key International's Chief Executive Officer and Chairman, Michael W. DePasquale, has acquired 4,000 shares of common stock at $0.83 per share through a pre-planned transaction.

Summary

• Michael W. DePasquale, the Chief Executive Officer and Chairman of BIO-key International, Inc. (BKYI), reported the acquisition of 4,000 shares of the company's common stock.
• The transaction occurred on June 3, 2025, at a price of $0.83 per share.
• This purchase was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.
• Following this acquisition, Mr. DePasquale directly beneficially owns 48,519 shares of common stock.
• His holdings do not include options to purchase an additional 232 shares.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant insider purchase by the CEO and Chairman, indicating strong confidence in the company's future. The transaction being part of a 10b5-1 plan adds a layer of pre-planning, but the act of buying itself is a strong positive signal.

Positives

• The purchase of shares by the CEO and Chairman, Michael W. DePasquale, signals confidence in the company's future prospects and valuation.
• The transaction was executed at $0.83 per share, indicating management's belief in the stock's value at this price point.
• The acquisition increases the CEO's direct beneficial ownership to 48,519 shares, aligning his interests further with shareholders.

Risks

• While an insider purchase is generally positive, it does not eliminate the inherent risks associated with investing in public equities, including market volatility and company-specific operational challenges.
• The value of the acquired shares is subject to market fluctuations, and there is no guarantee of future appreciation.

Future Outlook

The document does not provide explicit forward-looking statements or guidance beyond the details of the insider transaction itself. However, an insider purchase, especially by the CEO and Chairman, implicitly suggests a positive outlook on the company's future performance.

Management Comments

• The filing indicates that the transaction was made pursuant to a contract, instruction, or written plan for the purchase of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

This insider purchase by the CEO of BIO-key International, a company operating in the identity and access management sector, suggests confidence in the company's position and future within a growing market for biometric and security solutions. While specific industry trends are not detailed, insider buying can be a signal of perceived undervaluation or strong future prospects relative to the broader industry.

Stakeholder Impact

• Shareholders: The insider purchase by the CEO and Chairman may instill greater confidence among existing shareholders and potentially attract new investors, as it signals management's belief in the company's value and future performance.
• Employees: While not directly impacted, a positive signal from leadership can indirectly boost morale and confidence in the company's stability and direction.

Key Dates

Recommendation

Keywords

BIO-key International, BKYI, Insider Trading, Form 4, Stock Purchase, CEO, Chairman, Michael DePasquale, Equity Acquisition, Biometrics, Identity Management